Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlæge Søren Schantz ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5% 0.5%   Bankruptcy risk   7.6% 6.6% 6.4% 2.3% 4.4% 4.2% 7.0% 6.7%   Credit score (0-100)   34 37 37 63 47 47 34 36   Credit rating   BB BBB BBB BBB BBB BBB BBB BBB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   5,709 5,942 6,711 6,776 7,306 7,018 0.0 0.0   EBITDA   1,501 1,658 2,216 1,572 1,161 931 0.0 0.0   EBIT   1,174 1,304 1,839 1,164 755 513 0.0 0.0   Pre-tax profit (PTP)   -691.3 -387.2 -422.5 1,008.4 622.7 350.6 0.0 0.0   Net earnings   -749.0 -393.6 -290.4 776.5 476.7 260.2 0.0 0.0   Pre-tax profit without non-rec. items   -691 -387 -422 1,008 623 351 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   1,998 1,789 1,767 1,589 1,356 1,069 0.0 0.0   Shareholders equity total   701 253 -37.3 739 194 395 234 234   Interest-bearing liabilities   1,441 2,096 2,313 1,537 1,098 610 824 824   Balance sheet total (assets)   5,250 5,128 3,689 3,928 3,040 2,792 1,059 1,059   Net Debt   1,405 2,060 2,308 1,521 1,082 602 824 824     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   5,709 5,942 6,711 6,776 7,306 7,018 0.0 0.0   Gross profit growth   15.6% 4.1% 13.0% 1.0% 7.8% -3.9% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   5,250 5,128 3,689 3,928 3,040 2,792 1,059 1,059   Balance sheet change%   -62.6% -2.3% -28.1% 6.5% -22.6% -8.2% -62.1% 0.0%   Added value   1,501.2 1,657.9 2,216.0 1,572.5 1,164.3 931.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -8,709 -659 -494 -683 -735 -801 -1,069 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 4.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   20.6% 21.9% 27.4% 17.2% 10.3% 7.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   4.0% 19.3% 1.5% 29.5% 22.1% 17.4% 0.0% 0.0%   ROI %   5.8% 38.7% 2.8% 46.5% 38.6% 39.5% 0.0% 0.0%   ROE %   -65.9% -82.5% -14.7% 35.1% 102.1% 88.3% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   13.3% 4.9% -1.0% 18.8% 6.4% 14.2% 22.1% 22.1%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   93.6% 124.2% 104.1% 96.7% 93.2% 64.7% 0.0% 0.0%   Gearing %   205.7% 828.4% -6,199.1% 208.0% 565.3% 154.4% 351.6% 351.6%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   21.0% 78.6% 22.2% 6.2% 11.2% 18.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.1 0.1 0.1 0.4 0.2 0.3 0.0 0.0   Current Ratio   0.1 0.1 0.1 0.4 0.2 0.3 0.0 0.0   Cash and cash equivalent   36.3 36.8 5.2 16.1 15.4 8.5 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -3,588.5 -4,238.8 -3,191.3 -1,877.7 -2,203.1 -1,654.4 -412.2 -412.2   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   1,501 1,658 2,216 1,572 1,164 931 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   1,501 1,658 2,216 1,572 1,161 931 0 0   EBIT / employee   1,174 1,304 1,839 1,164 755 513 0 0   Net earnings / employee   -749 -394 -290 777 477 260 0 0